Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Dylan Berman

DARK SECRETS: Crispr stock surges in recent weeks what s going on - The Real Truth

Crispr Therapeutics

CRISPR Therapeutics AG (NASDAQ:CRSP) is trending Thursday, up more than 45% over the past month. Here’s a look at what’s driving the move.

What To Know: In late June, the company reported new early-stage data showing its experimental treatment CTX310 significantly lowered triglycerides and LDL cholesterol in patients, with no major safety issues. CRISPR Therapeutics said it plans to share full results in late 2025.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.